CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- 4 Planned sale EVP Gen Counsel, Legal & Comp sold 3,399 shares at $164.11 ($557,810)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chairman & CEO sold 112,429 shares at an average $175.16 ($19,693,439)
- 144 Insider Sale of Securities
- 13F-HR Other Quarterly Holdings of Institutional Investment Managers
- 144 Insider Sale of Securities
- 4 Planned sale Chairman & CEO sold 30,881 shares at an average $172.57 ($5,329,178)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $156.22 ($468,660)
- 4 Planned sale Chief Comm & Corp Aff Officer sold 3,000 shares at $156.22 ($468,660)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chairman & CEO sold 15,000 shares at an average $147.90 ($2,218,508)
- 4 Shares withheld for taxes SVP, Controllership gave up 768 shares (to pay taxes)
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $145.29 ($435,870)
- 4 Planned sale Chief Comm & Corp Aff Officer sold 3,000 shares at an average $144.22 ($432,646)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 160 · 3,185 filings